title: Angioedema due to the new oral anticoagulant rivaroxaban.
authors.affiliation: Department of Cardiology, Faculty of Medicine, University of Baskent, İzmir, Turkey.
authors.forename: Cihan
authors.initials: C
authors.lastname: Altin
authors.forename: Ovgu Anil Yakin
authors.initials: OA
authors.lastname: Ozturkeri
authors.forename: Esin
authors.initials: E
authors.lastname: Gezmis
authors.forename: Ulku
authors.initials: U
authors.lastname: Askin
mesh_terms: D000368:Aged; D000799:Angioedema / Q000139:chemically induced* / Q000503:physiopathology / Q000628:therapy; D000925:Anticoagulants / Q000009:adverse effects* / Q000627:therapeutic use; D001281:Atrial Fibrillation / Q000150:complications / Q000188:drug therapy; D004342:Drug Hypersensitivity / Q000628:therapy*; D004562:Electrocardiography; D005260:Female; D006801:Humans; D009025:Morpholines / Q000009:adverse effects* / Q000627:therapeutic use; D000069552:Rivaroxaban; D013876:Thiophenes / Q000009:adverse effects* / Q000627:therapeutic use
chemical_list: D000925:Anticoagulants; D009025:Morpholines; D013876:Thiophenes; D000069552:Rivaroxaban